XBiotech Inc. (XBIT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 117.05M | 126.95M | 148.95M | 154.89M | 157.69M | 174.57M | 185.03M | 190.64M | 203.06M | 201.72M | 204.4M | 209.51M |
| Cash & Short-Term Investments | 115.46M | 125.55M | 147.37M | 152.94M | 155.9M | 172.68M | 183.12M | 188.53M | 201.04M | 200.02M | 202.19M | 204.77M |
| Cash Only | 115.46M | 125.55M | 147.37M | 152.94M | 155.9M | 172.68M | 183.12M | 188.53M | 201.04M | 200.02M | 202.19M | 143.39M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 61.38M |
| Accounts Receivable | 302K | 360K | 450K | 638K | 638K | 858K | 871K | 993K | 945K | 935K | 1.33M | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.29M | 1.04M | 1.13M | 1.31M | 1.15M | 1.03M | 1.04M | 1.12M | 1.07M | 760K | 879K | 3.79M |
| Total Non-Current Assets | 22.79M | 23.13M | 23.47M | 23.79M | 24.18M | 24.53M | 24.82M | 24.92M | 24.8M | 24.9M | 25.2M | 25.62M |
| Property, Plant & Equipment | 22.79M | 23.13M | 23.47M | 23.79M | 24.18M | 24.53M | 24.82M | 24.92M | 24.8M | 24.9M | 25.2M | 25.62M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 139.84M | 150.08M | 172.42M | 178.68M | 181.86M | 199.09M | 209.85M | 215.56M | 227.86M | 226.62M | 229.6M | 235.14M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -23.11% | -24.62% | -17.84% | -17.11% | -20.19% | -12.14% | -8.6% | -8.33% | -5.89% | -7.92% | -8.47% | -11.76% |
| Total Current Liabilities | 3M | 7.93M | 3.56M | 3.86M | 5.41M | 15.11M | 15.99M | 17.14M | 16.88M | 6.1M | 5.29M | 4.45M |
| Accounts Payable | 857K | 1.53M | 1.04M | 1.43M | 1.1M | 2.22M | 1.51M | 1.7M | 2.61M | 2.52M | 1.47M | 1.82M |
| Days Payables Outstanding | 324.22 | - | - | - | - | - | - | - | - | 422.27 | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 10.25M | 10M | 10M | 10M | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.14M | 6.32M | 2.52M | 0 | 0 | 611K | 0 | 0 | 0 | 562K | 0 | 0 |
| Current Ratio | 39.03x | 16.01x | 41.78x | 40.16x | 29.15x | 11.56x | 11.57x | 11.13x | 12.03x | 33.07x | 38.61x | 47.08x |
| Quick Ratio | 39.03x | 16.01x | 41.78x | 40.16x | 29.15x | 11.56x | 11.57x | 11.13x | 12.03x | 33.07x | 38.61x | 47.08x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.82M | 1.8M | 1.78M | 1.76M | 1.74M | 1.72M | 1.74M | 1.72M | 1.69M | 1.67M | 1.65M | 1.62M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 5K | 5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.81M | 1.8M | 1.78M | 1.76M | 1.74M | 1.72M | 1.74M | 1.72M | 1.69M | 1.67M | 1.65M | 1.62M |
| Total Liabilities | 4.82M | 9.73M | 5.34M | 5.62M | 7.15M | 16.82M | 17.74M | 18.85M | 18.58M | 7.77M | 6.94M | 6.07M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 10.25M | 10M | 10M | 10M | 0 | 0 | 0 |
| Net Debt | -115.46M | -125.55M | -147.37M | -152.94M | -155.9M | -162.43M | -173.12M | -178.53M | -191.04M | -200.02M | -202.19M | -143.39M |
| Debt / Equity | - | - | - | - | - | 0.06x | 0.05x | 0.05x | 0.05x | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | -122.35x | -50.71x | -23.66x | - | - | - | - | - |
| Total Equity | 135.02M | 140.35M | 167.08M | 173.06M | 174.71M | 182.27M | 192.12M | 196.7M | 209.28M | 218.85M | 222.66M | 229.06M |
| Equity Growth % | -22.72% | -23% | -13.03% | -12.02% | -16.52% | -16.71% | -13.72% | -14.13% | -11.66% | -8.97% | -9.05% | -10.45% |
| Book Value per Share | 4.43 | 4.60 | 5.48 | 5.68 | 5.73 | 5.98 | 6.30 | 6.46 | 6.87 | 7.19 | 7.32 | 7.53 |
| Total Shareholders' Equity | 135.02M | 140.35M | 167.08M | 173.06M | 174.71M | 182.27M | 192.12M | 196.7M | 209.28M | 218.85M | 222.66M | 229.06M |
| Common Stock | 276.9M | 276.73M | 276.56M | 276.54M | 276.43M | 273.11M | 272.44M | 272.01M | 271.59M | 271.15M | 269.89M | 268.93M |
| Retained Earnings | -141.88M | -136.38M | -109.48M | -103.48M | -101.72M | -90.84M | -80.33M | -75.31M | -62.31M | -52.31M | -47.67M | -40.31M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 440K | 440K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |